The largest database of trusted experimental protocols

49 protocols using erk1 2

1

Protein Expression Analysis in Cell Lysates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were rinsed in lysis buffer (125 mM Tris-HCl, 750 mM NaCl, 1% v/v NP40, 10% v/v glycerol, 50 mM MgCl2, 5 mM EDTA, 25 mM NaF, 1 mM NaVO4, 10 μg/ml leupeptin, 10 μg/ml pepstatin, 10 μg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride, pH 7.5), sonicated and centrifuged at 13,000 x g for 10 min at 4°C. 20 μg cell lysates were subjected to Western blotting and probed with the following antibodies: phospho-(Thr202/Tyr204, Thr185/Tyr187)-ERK1/2 (Millipore); ERK1/2 (Millipore); HIF-1α (BD Bioscience, San Jose, CA); FPPS (Abcam, Cambridge, UK); Pgp/ABCB1 (Santa Cruz Biotechnology Inc., Santa Cruz, CA); MRP1/ABCC1 (Abcam); MRP2/ABCC2 (Abcam); MRP3/ABCC3 (Santa Cruz Biotechnology Inc.); MRP4/ABCC4 (Abcam); MRP5/ABCC5 (Santa Cruz Biotechnology Inc.); BCRP/ABCG2 (Santa Cruz Biotechnology Inc.); β-tubulin (Santa Cruz Biotechnology Inc.), followed by the secondary peroxidase-conjugated antibodies (Bio-Rad Laboratories). Proteins were detected by enhanced chemiluminescence (PerkinElmer, Waltham, MA). To assess HIF-1α phosphorylation, the whole cell lysate was immunoprecipitated with a polyclonal anti-HIF-1α antibody (Santa Cruz Biotechnology Inc.), then resolved by SDS-PAGE and probed with a biotin-conjugated anti-phosphoserine antibody (Sigma-Aldrich), followed by polymeric streptavidin-horseradish peroxidase-conjugates (Sigma-Aldrich).
+ Open protocol
+ Expand
2

Signaling Pathway Modulators in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture reagents were purchased from the Gibco Co. (Grand Island, NY, USA). Dimethyl sulphoxide, PD98059 [an extracellular regulated kinase (ERK1/2) inhibitor], SB203580 (a p38 kinase inhibitor), SP600125 [a Jun kinase (JNK) inhibitor], SB431542 (a type I TGF-β receptor inhibitor), LY294002 [a phosphoinositide-3 kinase (PI3K) inhibitor] and AG490 [a Janus kinase (JAK2) inhibitor] were purchased from the Sigma-Aldrich Co. (St. Louis, MO, USA). S100B was purchased from the Abcam Co. (Cambridge, UK).
The antibodies used were: S100B, collagen IV (col4α1), cyclooxygenase 2 (COX2), pan-cadherin (Abcam); Steap4 (Novus Biologicals, Littleton, CO, USA), fibronectin and RAGE (Chemicon, Temecula, CA, USA), ERK1/2, p-ERK1/2 (Thr202/Tyr204), p38 kinase, p-p38 kinase (Thr180/Try182), Akt, p-Akt (Thr308), Signal transducer and activator of transcription 3 (Stat3), p-Stat3 (Tyr705), Smad2/3, p-Smad2/3 (Ser433/435) (Cell Signaling Technology Inc., Danvers, MA, USA), GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and α-tubulin (Thermo Scientific, Fremont, CA, USA).
+ Open protocol
+ Expand
3

Western Blot Analysis of Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lysates (20 μg), prepared using lysis buffer [10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 0.2 mM sodium orthovanadate, 0.5% Nonidet P-40, 1% Triton X-100, and 1 mM PMSF], were resolved by 10% SDS-PAGE. The proteins were transferred onto PVDF membrane. The membranes were probed with primary antibodies directed against p-Akt (1:1000; Cell Signaling Tech.), p-ERK1/2 (1:2000; Cell Signaling Tech.), β3-integrin (1:1000; Santa Cruz), VEGF-A (1:200; Santa Cruz), or α-SMA (1:20,000; Sigma). The membranes were then stripped and probed with Akt, ERK1/2, actin (Chemicon) or GAPDH (Santa Cruz) antibodies to normalize protein loading. Band intensities were quantified using Kodak photo documentation system (Eastman Kodak Co.).
+ Open protocol
+ Expand
4

Investigating Luteolin and Selumetinib Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCT-116/HT-29 cells (2 × 106 cells) were seeded in a 100-mm dish. After treatment with luteolin and/or selumetinib for 48 h, cells were collected in PBS and lysed with radioimmunoprecipitation assay (RIPA) buffer (Beyotime Institute of Biotechnology, Beijing, China) on ice for 30 min, and lysates were harvested by centrifugal separation. Protein concentration was determined using the BCA Protein Assay Kit (Takara). Identical amounts of protein were separated using 10% sodium lauryl sulfate-polyacrylamide gel electrophoresis and then transferred to polyvinylidene difluoride membranes (Millipore, USA). The membranes were clogged with 5% nonfat dry milk for 1 h at room temperature. The primary antibodies BCL-2, BAX, cleaved caspase-3, cyclin B1, p-CHK1, CDC2, XRCC1, LIG1, HMGB1, ERCC3, p-MEK1, MEK1, p-ERK1/2, ERK1/2, and GAPDH (1:1000 dilution, Sigma-Aldrich) were added after overnight incubation at 4°C. After three washes with TBST, the membranes were incubated with anti-mouse horseradish peroxidase (HRP)-linked secondary antibodies (Beyotime Institute of Biotechnology, Beijing, China) for 1 h. The intensity of protein expression was measured using an enhanced chemiluminescence reagent (Thermo Fisher Scientific, USA) [31 (link),32 ].
+ Open protocol
+ Expand
5

Western Blot Analysis of Protein Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein samples were denatured by boiling in SDS sample buffer, and then electrophoresed in 7.5%, 10%, or 12% polyacrylamide gels. Proteins were transferred to a nitrocellulose membrane, then immunoblotted with appropriate primary antibodies [Dicer1 (Abcam, 1:500), Ago2 (Abcam, 1:500), Tau (Abcam, 1:500), α-tubulin (Abcam, 1:5000), GFP (Covance, 1:300), gERK (ERK 1/2, Sigma, 1:20000)] followed by HRP-conjugated secondary antibodies (1:10000, Jackson Laboratories) and visualized using myECL Imager (Thermo), according to the manufacturer's instructions. Quantification was performed using Image J software.
+ Open protocol
+ Expand
6

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lysates were isolated from the whole tissue homogenates or gastric cancer cells using a Total Protein Extraction kit (Millipore, Billerica, MA, USA) and were cytoplasmic and nuclear protein extracted using a Cytoplasmic and Nuclear Protein Extraction kit (Promega, Madison, WI, USA) and were subjected to western blot analysis. Antibodies against HMGB1 (1:8,000; Sigma), LC3B, ERK1/2, phospho-ERK1/2, p38, p38, AKT, phospho-AKT, JNK, phospho-JNK (1:1,000; Cell Signaling Technology, Danvers, MA, USA), RAGE (1:200; R&D Systems), β-tubulin, albumin and lamin B (1:1,000; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) were used to develop immunoreactive signals. Densitometry was performed using AlphaImager 2200 system and Quantity software.
+ Open protocol
+ Expand
7

Comprehensive Cell Lysis and Immunoblotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lyzed using 0.20% NP40, 50 mM Tris pH 7.5, 5% Glycerol, 1.5 mM MgCl2, 100 mM NaCl lysis buffer containing Phosphatase Inhibitor Cocktail 2 (Sigma, P5726) and cOmplete Protease Inhibitor Cocktail (Roche, 11873580001). Lysates were resolved by SDS-PAGE and incubated with primary antibodies. Antibodies used were against actin (A5441), CAMKK2 (HPA017389) (both Sigma), ERK1/2 (Sigma, M5670) and phospho-AKT (Ser473)(#9271), AKT (#9272), ALK(#3633), phospho-p90RSK (Ser380)(#12032), RSK1/2/3 (#9355), RSK1(#9333), RSK2 (#5528), phospho-RPS6 (Ser235/236)(#4858), RPS6 (#2217), phospho-ERK1/2 (Thr202/Tyr204)(#4267), phospho-FAK1 (Tyr397)(#8556), FAK1 (#13009), phospho-IGF1R (Tyr1131)(#3021), IGF1R (#9750), cleaved Caspase 3 (#9661), PARP-1 (#9542), AMPK1 (#2795), pAMPKα (Thr172)(#2535), FER (#4268), phospho-YB1 (Ser102)(#2900), and YB1 (#4202) were from Cell Signaling. Secondary antibodies were HRP-conjugated α-rabbit or α-mouse (GE Healthcare).
+ Open protocol
+ Expand
8

Western Blot Analysis of RNF135 and ERK

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lysates were prepared using radioimmunoprecipitation lysis buffer (Beyotime Institute of Biotechnology). The concentration of protein lysate was determined with Pierce Bicinchoninic Acid Protein Assay kit (Thermo Fisher Scientific, Inc.). A total of 20 µg protein were loaded per lane and separated via SDS-PAGE on an 8% gel. The separated proteins were then transferred to polyvinylidene difluoride membranes and subsequently blocked with 5% non-fat milk at room temperature for 1 h. Then membranes were incubated with primary antibodies anti-RNF135 (cat. no. ab28636; 1:1,000; Abcam), anti-GAPDH (cat. no. G8795; 1:8,000; Sigma-Aldrich; Merck KGaA), ERK1/2 (cat. no. 4695; 1:1,000; Cell Signaling Technology, Inc.) and phosphorylated (p-) ERK1/2 (cat. no. 9101; 1:1,000; Cell Signaling Technology, Inc.) at 4°C overnight. Following primary incubation, membranes were incubated with horseradish peroxidase-labeled secondary mouse antibody (cat. no. AP308P; 1:10,000; Sigma-Aldrich; Merck KGaA) and rabbit antibody (cat. no. SAB3700852; 1:10,000; Sigma-Aldrich; Merck KGaA) at room temperature for 1 h. Subsequently, the bands were visualized using enhanced chemiluminescence western blotting detection reagents (GE Healthcare Life Sciences). Images were captured and analyzed using ImageQuant TL 7.0 (GE Healthcare Life Sciences). GAPDH served as a loading control for protein quantification.
+ Open protocol
+ Expand
9

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell protein extracts were obtained using the CelLytic Mammalian Cell Lysis/Extraction Reagent (Sigma-Aldrich) with protease and phosphatase inhibitor cocktails (Sigma-Aldrich). Protein concentration was determined using the Bradford protein assay (Bio-Rad Laboratories, Hercules, CA, USA). Thirty micrograms of protein were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a PVDF membrane (GE HealthCare, Freiburg, Germany). The membranes were blocked in 5% non-fat dry milk in Tris-buffered saline containing 10% Tween 20. Antibodies against SET (E15; #sc-5655; Santa Cruz), ERK1/2 (M 5670; Sigma-Aldrich), phospho-p44/42 MAPK ERK1/2 (pERK1/2; #4377; Cell Signaling, Rockford, IL, USA), PP2Ac (PP2A catalytic subunit; #2038; Cell Signaling), p53 (7 F5; #2527; Cell Signaling), phospho-p53 (p-p53Ser15; #9286; Cell Signaling), p21WAF1/Cip1 (12D1; #2974; Cell Signaling), β-actin and tubulin were used. The reactions were developed using the chemiluminescent ECL Western blotting system (GE HealthCare). Densitometric analysis was performed using the ImageJ 6.4 software [43 (link)], and bands were normalized to constitutive proteins. The values are presented as the shSET/shControl ratio. For phosphorylation analysis, the phosphorylated/total protein ratio was calculated, and representative values are presented.
+ Open protocol
+ Expand
10

Antibody Validation for Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used were HA (SC-805, Santa Cruz, Dallas, TX), HA-7-HRP (H6533, Sigma-Aldrich), MEK1/2 (#9126, Cell Signaling, Danvers, MA), phospho-MEK1/2 (#2338, Cell Signaling), ERK1/2 (M5670, Sigma-Aldrich), phospho- ERK1/2 (#4370, Cell Signaling), STAT5 (610191, BD Biosciences, Franklin Lakes, NJ), phospho-STAT5A/B (05–886R, Merck Millipore), phospho-p70 S6 kinase (#9234, Cell Signaling), p70 S6 kinase (SC-230, Santa Cruz), RIPK3 (#12107, Cell Signaling), HSP90 (610418, BD Transduction Laboratories), actin (AAN01-A, Cytoskeleton, Denver, CO), and tubulin (ab7291, Abcam, Cambridge, UK). The secondary antibodies used were goat anti-mouse HRP (115–035-003, Jackson ImmunoResearch, West Grove, PA), goat anti-rabbit HRP (111–035-003, Jackson ImmunoResearch), and Alexa Fluor 680 goat anti-mouse (A-21057, Molecular probes, Grand Island, NY).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!